Can sodium valproate sustained-release tablets be discontinued abruptly?
Aug 03, 2023
Source: Cainiu Health
Dr. Yang Jun
Introduction
In general, sodium valproate sustained-release tablets should not be discontinued abruptly. The dosage should be gradually reduced according to medical advice until the medication is completely stopped. Sodium valproate sustained-release tablets are an antiepileptic drug primarily used for the treatment of epilepsy and should usually not be stopped suddenly. Gradual dose reduction is necessary to prevent recurrence of the condition. During the discontinuation process, patients should closely monitor their physical condition.
Under normal circumstances, sodium valproate sustained-release tablets should not be discontinued abruptly. The dosage should be gradually reduced according to medical instructions until the medication is completely stopped. Specific details are as follows:
Sodium valproate sustained-release tablets are an antiepileptic medication primarily used for treating epilepsy. It is generally not advisable to stop using this medication suddenly; instead, the dose should be tapered gradually to prevent a recurrence of symptoms. During the discontinuation process, patients should closely monitor their physical condition and promptly report any abnormalities or discomfort to their doctor. Some patients may experience withdrawal symptoms when discontinuing sodium valproate sustained-release tablets, such as anxiety, insomnia, or headaches. If these symptoms occur, patients should consult their doctor regarding possible interventions, such as appropriate alternative medications or other supportive treatments. It is recommended that patients strictly follow their doctor's instructions and adhere to the prescribed tapering schedule, avoiding self-initiated discontinuation or dose adjustments, which could lead to adverse reactions or worsening of symptoms.
It is important to note that before discontinuing any medication, it is best to first consult a physician. The doctor will provide individualized guidance on discontinuation based on the patient’s specific medical condition and personal circumstances.
